Atomwise Company

Atomwise uses artificial intelligence for drug discovery. We design new molecules for the hardest targets. Our discoveries help our partners deliver better medicines faster.


Connections from

Last Funding Type: Grant
Funding Status: Early Stage Venture
Headquarters: United
Founded Date: 2012-01-01
Investor Type: For Profit
Last Funding Date: 2020-10-06
Total Funding: 176645000.0
Technology: ['BioTech & HealthTech']
Employee Number: 94
Estimated Revenue: 2.3
Investors Number: 22.0
Industry: Application Software